Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-655-4 | CAS number: 67-48-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- no information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Choline is required in the diet of lactating dams to maintain maternal immune function
- Author:
- Dellschaft NS, et al.
- Year:
- 2 015
- Bibliographic source:
- British Journal of Nutrition (2015), 113, 1723–1731
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Primiparous Sprague–Dawley rats (n 42) were randomised 24-48 h before birth and fed the following diets for 21 d: choline-devoid (0 g choline/kg diet; D, n=10); 1.0 g choline/kg diet (C1, n=11); 2.5 g choline/kg diet (C2.5, n=10); 6.2 g choline/kg diet (C6, n=11). The effects of varying intakes of choline on maternal immune function during lactation were determined testing several parameters (liver total fat content, choline metabolite analyses of pup stomach content, immune cell phenotype analysis and ex vivo cytokine secretion by mitogen-stimulated splenocytes).
- GLP compliance:
- not specified
- Type of method:
- in vivo
Test material
- Reference substance name:
- Choline
- EC Number:
- 200-535-1
- EC Name:
- Choline
- Cas Number:
- 62-49-7
- Molecular formula:
- C5H14NO
- IUPAC Name:
- 2-hydroxy-N,N,N-trimethylethanaminium
Constituent 1
- Specific details on test material used for the study:
- Choline was added to the diets in the form of choline bitartrate obtained from Harland Teklad
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: Primiparous Sprague–Dawley rats were obtained on day 14 of gestation
- Diet (e.g. ad libitum): Diets were fed ad libitum throughout lactation to the end of the study at 21 d postnatal. Animals were provided free access to food throughout each 24 h period
Administration / exposure
- Route of administration:
- oral: feed
- Details on exposure:
- Dams were fed standard rat chow (Lab diet 5001; PMI Nutrition International, containing 1 g choline/kg; Harland Teklad) throughout gestation, then randomised to one of four experimental diets (D, choline-deficient diet; C1, 1.0 g choline/kg diet; C2.5, 2.5 g choline/kg diet; C6, 6.2 g choline/kg diet) 24–48 h before parturition. Diets were fed ad libitum throughout lactation to the end of the study at 21 d postnatal.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The content of choline in the salt was verified by analysis before adding it to the diets.
- Duration of treatment / exposure:
- 21 d
- Frequency of treatment:
- continuous
- Duration of test:
- After 21 days of parturition, dams and two pups per dam were weighed and killed by CO2 asphyxiation and subsequent cervical dislocation in the morning hours.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 other: g/kg diet
- Remarks:
- D
- Dose / conc.:
- 1 other: g/kg diet
- Remarks:
- C1, corresponding to 200 mg choline/kg bw/day
- Dose / conc.:
- 2.5 other: g/kg diet
- Remarks:
- C2.5, corresponding to 500 mg choline/kg bw/day
- Dose / conc.:
- 6.2 other: g/kg diet
- Remarks:
- C6, corresponding to 1240 mg choline/kg bw/day
- No. of animals per sex per dose:
- D (n=8, two of the original ten dams in the D group had to be killed before the end of the experiment due to significant weight loss), C1 (n=11), C2.5 (n=10), C6 (n=11)
- Control animals:
- yes, plain diet
- Details on study design:
- The effects of varying intakes of choline on maternal immune function during lactation were determined in primiparous Sprague–Dawley rats treated for 21 days testing the following parameters: Anthropometric characteristics, Liver total fat content, Choline metabolite analyses of pup stomach content, immune cell phenotype analysis and ex vivo cytokine secretion by mitogen-stimulated splenocytes.
- Statistics:
- Statistical analyses were conducted using SAS statistical software (version 9.3; SAS Institute, Inc.). Data were analysed for normal distribution in each dietary group with the use of a Kolmogorov–Smirnov test. Parametric data were subsequently analysed for differences by ANOVA and Tukey post hoc testing was used. Regression analysis was used to test the relationship between dietary choline intake and the concentration of free and total choline in the stomach content of the offspring. Non-parametric data were log-transformed before analysis by ANOVA as above. In some instances, logtransformation did not lead to normal distribution of the data, and groups were compared similarly using Mann–Whitney U-tests. For all statistical tests, significance was accepted with a CI of 95% (P<0.05). All results are presented as means with their standard errors and the actual number of values available for each measure is indicated with the results.
Results and discussion
Observed effects
Applicant's summary and conclusion
- Conclusions:
- Oral administration of choline at test concentrations up to 6.2 g choline/kg diet, corresponding to 1240 mg choline/kg bw/day, to pregnant rats for 21 d starting 24-48 h before parturition to ensure exposure at initiation of suckling was found to decrease body weights of dams and pups at the highest test concentration (-15% and -20% compared to standard diet containing 1 g choline/kg diet for dams and pups, respectively) but had no effect on the different immune cell phenotypes in the spleen and only a minimal effect on maternal immune cell function at the highest dose level. Noticeably, this study found that choline is required to maintain maternal immune function in lactating dams.
- Executive summary:
The present study was designed to determine the effects of varying intakes of choline on maternal immune function during lactation.
Primiparous Sprague–Dawley rats (n 42) were randomised 24-48 h before birth and fed the following diets for 21 d: choline-devoid (0 g choline/kg diet; D, n=10); 1.0 g choline/kg diet (C1, n=11); 2.5 g choline/kg diet (C2·5, n=10); 6.2 g choline/kg diet (C6, n=11).
There was a linear relationship between free choline concentration in pup stomach contents with maternal dietary choline content. Compared with C1 and C2.5, D spleens had a lower proportion of mature T cells and activated suppressor cells, and this resulted in reduced cytokine production after stimulation. Feeding 6.2 g choline/kg diet resulted in a higher cytokine production after stimulation with CD3/CD28. Except for a higher IL-6 production after LPS stimulation with cells from the C2.5 dams, there were no differences between the C1 and C2.5 dams.
Oral administration of choline at test concentrations up to 6.2 g choline/kg diet, corresponding to 1240 mg choline/kg bw/day, to pregnant rats for 21 d starting 24-48 h before parturition to ensure exposure at initiation of suckling was found to decrease body weights of dams and pups at the highest test concentration (-15% and -20% compared to standard diet containing 1 g choline/kg diet for dams and pups, respectively) but had no effect on the different immune cell phenotypes in the spleen and only a minimal effect on maternal immune cell function at the highest dose level. Noticeably, this study found that choline is required to maintain maternal immune function in lactating dams.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.